said a spokesperson for the Public Health Agency of Canada. Now multiple studies, including Dormuth's, are shedding light on where Pfizer's drug actually fits into the COVID treatment picture at ...

During National Immunization Awareness Week, Pfizer Canada and McMaster University are proud to announce a significant project aimed at addressing critical gaps in health equity in the development and ...

TrialSite News features a paper published today in Viruses (Basel), authored by an international team of researchers, ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene ...

COVID vaccine booster shots were rolled out, and about 40 percent of US adults said they did not plan on getting a booster.

GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

A GSK spokesperson said the company believes its patents "provided the foundational technology used in Pfizer and BioNTech’s COVID-19 mRNA vaccines," and that it is "willing to license these ...

A three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), has resulted in a new AI-driven drug discovery method that could ...

A GSK spokesperson said the company believes its patents "provided the foundational technology used in Pfizer and BioNTech’s COVID-19 mRNA vaccines," and that it is "willing to license these ...

LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal ...

Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and ...